Award
National Cancer Institute 5R01CA293514-02
CAR neutrophils produced in vivo to remodel tumor microenvironment and treat glioblastoma
Recipient
National Cancer Institute (NCI), part of the National Institutes of Health (NIH)
Award Amount
$641,936.00
Ceiling
$641,936.00
Awarded
April 21, 2025
Identifier
5R01CA293514-02
Award for research project to engineer CAR neutrophils in vivo to treat glioblastoma, funded by NIH/NCI.
Description
This project involves engineering neutrophils with chimeric antigen receptors (CARs) directly in vivo to target glioblastoma, utilizing synthetic biology, machine learning, and animal models. The funding is provided by the NIH/NCI, with a focus on innovative cancer immunotherapy approaches.